Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, April 24 2014 3:23am ET - U.S. Markets open in 6 hours and 7 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Wednesday, Apr 23, 2014
·Can Endo's CEO Do An Encore Of His Playbook At Valeant? Guru Funds Think So.
at Seeking Alpha - Wed 6:28 pm ET
·[$$] Three Valeant Directors Won't Be Nominated for Re-Election
at The Wall Street Journal Online - Wed 5:45 pm ET
·DURECT Corporation Invites You to Join its First Quarter 2014 Earnings Conference Call
PR Newswire - Wed 5:40 pm ET
·Train Reading: Apple to Apples, The Wire to Prime
at The Wall Street Journal Online - Wed 4:13 pm ET
·Will Eli Lilly (LLY) Keep Its Earnings Streak Alive?
Zacks.com - Wed 4:10 pm ET
·[video] CEOs terrified of activists: Buffett
at CNBC - Wed 3:19 pm ET
·In Allergan Bid, a Question of Insider Trading
at The New York Times - Wed 3:01 pm ET
·ContraVir Strengthens Its Board of Directors with the Addition of Virology Expert, Scientist, and Entrepreneur, Timothy M. Block, Ph.D.
Business Wire - Wed 3:00 pm ET
·Ackman Left Trail as He Built Allergan Stake
at The Wall Street Journal Online - Wed 2:56 pm ET
·Valeant CEO 'disappointed' in Allergan poison pill: CNBC
Reuters - Wed 2:36 pm ET
·Dealpolitik: Valeant, Ackman Unveil New Approach to Hostile Takeovers
at The Wall Street Journal Online - Wed 2:09 pm ET
·[video] Bill Ackman's 'quiet' trade
at CNBC - Wed 1:34 pm ET
·[video] Hedge fund & big pharma pair up
at CNBC - Wed 1:32 pm ET
·[video] How Ackman built Allergan stake
at CNBC - Wed 12:41 pm ET
·Ackman's Allergan play: Not insider trading, not a problem for private equity
at Fortune - Wed 12:39 pm ET
·[video] Ackman: We Don’t Want to Partner With Everyone
at Bloomberg - Wed 12:29 pm ET
·[video] Ackman: Allergan Not Being Raided in Valeant Deal
at Bloomberg - Wed 11:42 am ET
·[video] Ackman: Pharma Industry Ripe for Synergies on Costs
at Bloomberg - Wed 10:49 am ET
·[video] Ackman: Why I’m Electing Stock in Allergan Deal
at Bloomberg - Wed 10:28 am ET
·Deals of the Day: Allergan's Poison Pill, Einhorn's 'Tech Bubble'
at The Wall Street Journal Online - Wed 10:11 am ET
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
Paperless Reg Docs
Secure online portal for clinical study start-up.
www.ePharmaSolutions.com
Purdue Research Trials
HCPs: Interested in Purdue Pharma's Clinical Trials? Sign Up Today.
www.PurduePharma.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?